Posted by HelenER on July 7, 2006, at 7:37:24
In reply to Re: agomelatine (Valdoxan) - FDA? not quite yet, posted by Larry C on April 18, 2006, at 20:20:11
I was interested to read these posts and not sure if it is still active, but one thing that I found curious was that agomelatine seems to have a short patent, possibly expiring before it ever reaches the market in the US, so why would Novartis bother to invest in it?
poster:HelenER
thread:479920
URL: http://www.dr-bob.org/babble/20060701/msgs/664801.html